The Insulin Pricing Wars Are Just Getting Started — Don’t let Eli Lilly’s latest P.R. stunt fool you: Private companies shouldn’t be allowed to set prices for these lifesaving drugs in the first place.

The Insulin Pricing Wars Are Just Getting Started — Don’t let Eli Lilly’s latest P.R. stunt fool you: Private companies shouldn’t be allowed to set prices for these lifesaving drugs in the first place. submitted by /u/thenewrepublic
[link] [comments]

Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay

Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay submitted by /u/CBSnews
[link] [comments]


source https://www.reddit.com/r/Health/comments/11hfyqf/ozempiclike_weight_loss_drug_wegovy_coming_to_the/

Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay

Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay
Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay submitted by /u/CBSnews
[link] [comments]
https://ift.tt/chxz0r2 March 04, 2023 at 03:15AM https://ift.tt/TPAvNBt

Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay

Ozempic-like weight loss drug Wegovy coming to the U.K. market, and it will cost a fraction of what Americans pay submitted by /u/CBSnews
[link] [comments]

Walgreens won’t distribute abortion pills in some states where they remain legal

Walgreens won’t distribute abortion pills in some states where they remain legal submitted by /u/marji80
[link] [comments]

Active COVID cases in country climb to 2,525

Active COVID cases in country climb to 2,525 The COVID case tally was recorded at 4.46 crore (4,46,87,162) and the national recovery rate has been recorded at 98.80 per cent, the ministry said. https://ift.tt/L0NPsBH

US FDA panel to review expanded use of Merck AstraZeneca's cancer drug

US FDA panel to review expanded use of Merck AstraZeneca's cancer drug The companies' are seeking approval of the drug Lynparza in combination with other medications - biraterone and prednisone or prednisolone -for the treatment of a type of treatment-resistant prostate cancer in adult patients. https://ift.tt/L0NPsBH